Status: Not yet recruiting
Real-World Study of the Safety and Efficacy of Surufatinib in the Treatment of Neuroendocrine Tumors
Prior clinical trials have demonstrated promising efficacy and manageable safety of surufatinib in neuroendocrine tumors (NETs). This real-world study aims to evaluate the clinical efficacy and safety of surufatinib in patients with NETs, providing additional real-world evidence to support clinical application, guide novel therapeutic strategies, and ultimately improve patient outcomes.
Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: YefengUpdated: Aug 21, 2026Locations: 1
Eligibility criteria
Patients with pathologically or cytologically confirmed neuroendocrine tumors; [+3]
Participation in other drug clinical trials with investigational drug treatment... [+4]